95635-56-6

• 常用中文名：N-(2,6-二甲基苯基)-2-(4-(2-羟基-3-(2-甲氧基苯氧基)-丙基)哌嗪-1-基)乙酰胺 二盐酸盐
• 常用英文名：Ranolazine dihydrochloride
• CAS号：95635-56-6
• 分子式：C₂₄H₃₅Cl₂N₃O₄
• 分子量：500.458
• 相关类别： 生物化工 抑制剂 跨膜转运体(Transmembrane Transporters) Calcium Channel 抑制剂
• 发布时间：2018-02-16 08:00:00
• 更新时间：2026-06-30 21:22:45
• Ranolazine双盐酸盐具有抗心律失常活性。

名称

• 中文名: 盐酸雷诺嗪
• 英文名: Ranolazine dihydrochloride
• 中文别名: 盐酸雷诺嗪,10 MM DMSO 溶液; 雷诺嗪二盐酸化物, 一种抗缺血剂; Ranolazine 2HCl 盐酸雷诺嗪，S1425; 雷诺嗪二盐酸盐; 雷诺嗪(标准品); 雷诺嗪盐酸盐; 雷喏嗪; 雷诺嗪二盐酸化物; N-(2,6-二甲基苯基)-2-(4-(2-羟基-3-(2-甲氧基苯氧基)丙基)哌嗪-1-基)乙酰胺二盐酸盐; 雷渃嗪; 雷诺嗪/Ranolazine dihydrochloride/95-6; Ranolazine 2HCl 盐酸雷诺嗪,S1425; 雷诺嗪及其盐; N-(2,6-二甲基苯基)-4-[2-羟基-3-(2-甲氧苯氧基)丙基]-1-哌嗪乙酰胺盐酸盐
• 英文别名: Ranolazine dihydrochloride, 10 mM in DMSO; N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)-propyl)piperazin-1-yl)acetamide dihyd; (+/-)-4-[2-HYDROXY-3-(O-METHOXYPHENOXY)PROPYL]-1-PIPERAZINEACETO-2',6'-XYLIDIDE DIHYDROCHLORIDE; N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]ethanamide dihydrochloride; N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide dihydrochloride; MFCD03788770; RANOLAZINE DI HCL; Ranolazine dihydrochloride,(±) -4-[2-Hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2′,6′-xylidide dihydrochloride, N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazinea; Ranolazine dihydrochloride N-(2,6-Dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide dihydrochloride; 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, hydrochloride (1:2); RS 43; Ranolazine2Hcl; (±) -4-[2-Hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2μ,6μ-xylidide dihydrochloride, N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide dihydrochloride; Ranolazine dihydrochlorideQ: What is Ranolazine dihydrochloride Q: What is the CAS Number of Ranolazine dihydrochloride Q: What is the storage condition of Ranolazine dihydrochloride Q: What e the applications of Ranolazine dihydrochloride; Ranolazine dihydrochloride an anti-ischemic agent; Ranolazine dihydroch; N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide Dihydrochloride; (±)-Ranolazine-d8 2HCl; Ranolazine dihydrochloride, Anti-ischemic agent; Ranolazine dihydrochloride //BP; 1-Piperazineacetamide,N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, hydrochloride(1:2); Ranolazine (hydrochoride); azine dihydrochL; RANOLAZINE HCL; Ranolazine (dihydrochloride); N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazinyl}acetamide dihydrochloride; (±)-N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide; (+/-)-N-(2,6-DIMETHYLPHENYL)-4-[2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL]-1-PIPERAZINEACETAMIDE DIHYDROCHLORIDE; N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)-propyl)piperazin-1-yl)acetamide di; Ranolazine DiHCI; Ranolazine and salt; n-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide dihydrochloride; Ranolazine Dihydrochloride >; Ranolazine Dihydrocloride; Ranolazine 2HCl; RANOLAZINE DIHYDROCHLORIDE; N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazinyl]acetamide dihydrochloride; (+/-)-1-[3-(2-Methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-diMethylphenyl)aMinocbonylMethyl]piperazine; Ranolazine 2HCl (RS-43285; N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide dihydrochloride

物化性质

• 沸点: 624.1ºC at 760 mmHg
• 熔点: 222-229.5ºC(lit.)
• 分子式: C₂₄H₃₅Cl₂N₃O₄
• 分子量: 500.458
• 精确质量: 499.200470
• PSA: 74.27000
• LogP: 3.86080
• 外观性状: solid | off-white
• 储存条件: Desiccate at RT
• 水溶解性: H2O: 10 mg/mL, soluble

生物活性

• 描述: Ranolazine双盐酸盐具有抗心律失常活性。
• 相关类别:
  信号通路 >> 自噬 >> 自噬
  信号通路 >> 跨膜转运 >> 钙通道
  信号通路 >> 跨膜转运 >> 钠通道
  研究领域 >> 心血管疾病
• 参考文献:

  [1]. Hawwa N, Menon V. Ranolazine: Clinical Applications and Therapeutic Basis. Am J Cardiovasc Drugs. 2013 Jan 19.

  [2]. Keating GM. Ranolazine: A Review of Its Use as Add-On Therapy in Patients with Chronic Stable Angina Pectoris. Drugs. 2013 Jan;73(1):55-73.

  [3]. Wang WQ, Robertson C, Dhalla AK, Belardinelli L. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits. J Pharmacol Exp Ther. 2008 Jun;325(3):875-81. doi: 10.1124/jpet.108.137729. Epub 2008 Mar 5.

  [4]. Shryock JC, Belardinelli L. Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardium. Br J Pharmacol. 2008 Mar;153(6):1128-32. Epub 2007 Dec 10.

  [5]. Zacharowski K, Blackburn B, Thiemermann C. Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat. Eur J Pharmacol. 2001 Apr 20;418(1-2):105-10.

安全

• 个人防护装备: Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
• 安全声明 (欧洲): S22-S24/25
• 危险品运输编码: NONH for all modes of transport
• WGK德国: 3
• 海关编码: 2942000000

海关

海关编码	2942000000